| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 | 17 | 17 | 13 | 15 | 27 | 10 | 8 | 8 | 1,853 | 40 | 30 | |
Growth YoY Revenue Growth YoY% | -65.3 | -29.8 | -39.3 | 7.6 | 64.2 | -42.6 | -38.9 | -43.3 | 6,715.8 | 314.1 | 282.1 | |
| 116 | 122 | 110 | 116 | 89 | 80 | 62 | 74 | 65 | 80 | 74 | 76 | |
| -103 | -106 | -93 | -103 | -74 | -53 | -52 | -66 | -57 | 1,773 | -34 | -46 | |
OPM OPM% | -740.4 | -639.1 | -555.4 | -800.2 | -494.2 | -195.6 | -540.3 | -836.1 | -670.3 | 95.7 | -85.2 | -151.9 |
| 6 | 4 | 2 | 0 | 0 | 0 | 9 | 0 | -12 | 2 | 24 | 24 | |
Interest Expense Interest ExpenseCr | 0 | 1 | 1 | 1 | 3 | 5 | 6 | 8 | 9 | 12 | 8 | 0 |
Depreciation DepreciationCr | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 |
PBT PBTCr | -100 | -105 | -96 | -107 | -79 | -61 | -52 | -76 | -80 | 1,761 | -21 | -24 |
| 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| -100 | -106 | -96 | -107 | -80 | -60 | -52 | -76 | -80 | 1,761 | -21 | -24 | |
Growth YoY PAT Growth YoY% | -29.0 | -0.6 | -24.2 | 20.2 | 43.5 | 45.9 | 29.3 | -1.1 | 3,046.9 | 59.9 | 67.8 | |
NPM NPM% | -719.0 | -638.8 | -570.5 | -834.6 | -533.3 | -219.8 | -538.1 | -965.0 | -951.7 | 95.0 | -52.0 | -81.2 |
| -3.1 | -3.3 | -3.0 | -3.3 | -2.5 | -1.8 | -1.6 | -2.3 | -2.5 | 54.3 | -0.6 | -0.8 |
| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 | 17 | 17 | 13 | 15 | 27 | 10 | 8 | 8 | 1,853 | 40 | 30 | |
Growth YoY Revenue Growth YoY% | -65.3 | -29.8 | -39.3 | 7.6 | 64.2 | -42.6 | -38.9 | -43.3 | 6,715.8 | 314.1 | 282.1 | |
| 116 | 122 | 110 | 116 | 89 | 80 | 62 | 74 | 65 | 80 | 74 | 76 | |
| -103 | -106 | -93 | -103 | -74 | -53 | -52 | -66 | -57 | 1,773 | -34 | -46 | |
OPM OPM% | -740.4 | -639.1 | -555.4 | -800.2 | -494.2 | -195.6 | -540.3 | -836.1 | -670.3 | 95.7 | -85.2 | -151.9 |
| 6 | 4 | 2 | 0 | 0 | 0 | 9 | 0 | -12 | 2 | 24 | 24 | |
Interest Expense Interest ExpenseCr | 0 | 1 | 1 | 1 | 3 | 5 | 6 | 8 | 9 | 12 | 8 | 0 |
Depreciation DepreciationCr | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 |
PBT PBTCr | -100 | -105 | -96 | -107 | -79 | -61 | -52 | -76 | -80 | 1,761 | -21 | -24 |
| 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| -100 | -106 | -96 | -107 | -80 | -60 | -52 | -76 | -80 | 1,761 | -21 | -24 | |
Growth YoY PAT Growth YoY% | -29.0 | -0.6 | -24.2 | 20.2 | 43.5 | 45.9 | 29.3 | -1.1 | 3,046.9 | 59.9 | 67.8 | |
NPM NPM% | -719.0 | -638.8 | -570.5 | -834.6 | -533.3 | -219.8 | -538.1 | -965.0 | -951.7 | 95.0 | -52.0 | -81.2 |
| -3.1 | -3.3 | -3.0 | -3.3 | -2.5 | -1.8 | -1.6 | -2.3 | -2.5 | 54.3 | -0.6 | -0.8 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
Revenue RevenueCr | 239 | 76 | 72 | 1,879 | 1,932 |
Growth Revenue Growth% | -68.4 | -5.0 | 2,518.5 | 3,141.0 | |
| 453 | 478 | 395 | 280 | 295 | |
| -214 | -402 | -323 | 1,599 | 1,637 | |
OPM OPM% | -89.7 | -532.3 | -450.3 | 85.1 | 84.7 |
| 11 | 29 | 2 | -1 | 37 | |
Interest Expense Interest ExpenseCr | 8 | 2 | 9 | 34 | 29 |
Depreciation DepreciationCr | 12 | 13 | 12 | 10 | 9 |
PBT PBTCr | -223 | -387 | -343 | 1,553 | 1,636 |
| 0 | 0 | 0 | 0 | 0 | |
PAT PATCr | -223 | -387 | -343 | 1,553 | 1,636 |
Growth PAT Growth% | -74.0 | 11.6 | 553.5 | 712.6 | |
NPM NPM% | -93.2 | -512.6 | -477.3 | 82.7 | 84.7 |
| -7.8 | -11.9 | -10.6 | 47.9 | 50.4 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
Revenue RevenueCr | 239 | 76 | 72 | 1,879 | 1,932 |
Growth Revenue Growth% | -68.4 | -5.0 | 2,518.5 | 3,141.0 | |
| 453 | 478 | 395 | 280 | 295 | |
| -214 | -402 | -323 | 1,599 | 1,637 | |
OPM OPM% | -89.7 | -532.3 | -450.3 | 85.1 | 84.7 |
| 11 | 29 | 2 | -1 | 37 | |
Interest Expense Interest ExpenseCr | 8 | 2 | 9 | 34 | 29 |
Depreciation DepreciationCr | 12 | 13 | 12 | 10 | 9 |
PBT PBTCr | -223 | -387 | -343 | 1,553 | 1,636 |
| 0 | 0 | 0 | 0 | 0 | |
PAT PATCr | -223 | -387 | -343 | 1,553 | 1,636 |
Growth PAT Growth% | -74.0 | 11.6 | 553.5 | 712.6 | |
NPM NPM% | -93.2 | -512.6 | -477.3 | 82.7 | 84.7 |
| -7.8 | -11.9 | -10.6 | 47.9 | 50.4 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 32 | 32 | 32 | 32 | 32 |
Reserves ReservesCr | 480 | 93 | -249 | 1,306 | 1,410 |
| 179 | 265 | 374 | 754 | 182 | |
| 138 | 124 | 178 | 78 | 50 | |
| 830 | 515 | 336 | 2,171 | 1,674 | |
| 455 | 269 | 26 | 1,862 | 1,390 | |
| 375 | 246 | 309 | 308 | 283 | |
| 830 | 515 | 336 | 2,171 | 1,674 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 32 | 32 | 32 | 32 | 32 |
Reserves ReservesCr | 480 | 93 | -249 | 1,306 | 1,410 |
| 179 | 265 | 374 | 754 | 182 | |
| 138 | 124 | 178 | 78 | 50 | |
| 830 | 515 | 336 | 2,171 | 1,674 | |
| 455 | 269 | 26 | 1,862 | 1,390 | |
| 375 | 246 | 309 | 308 | 283 | |
| 830 | 515 | 336 | 2,171 | 1,674 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| -69 | -429 | -360 | -239 | |
| -548 | 392 | 158 | -24 | |
| 617 | 42 | 199 | 261 | |
Net Cash Flow Net Cash FlowCr | -1 | 5 | -3 | -1 |
Free Cash Flow Free Cash FlowCr | -84 | -455 | -370 | -262 |
CFO To PAT CFO To PAT% | 31.1 | 110.8 | 105.2 | -15.4 |
CFO To EBITDA CFO To EBITDA% | 32.3 | 106.7 | 111.5 | -14.9 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| -69 | -429 | -360 | -239 | |
| -548 | 392 | 158 | -24 | |
| 617 | 42 | 199 | 261 | |
Net Cash Flow Net Cash FlowCr | -1 | 5 | -3 | -1 |
Free Cash Flow Free Cash FlowCr | -84 | -455 | -370 | -262 |
CFO To PAT CFO To PAT% | 31.1 | 110.8 | 105.2 | -15.4 |
CFO To EBITDA CFO To EBITDA% | 32.3 | 106.7 | 111.5 | -14.9 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 5,824 | 12,006 | 4,803 | 3,719 | 6,171 |
Price To Earnings Price To Earnings | 2.4 | 3.8 | |||
Price To Sales Price To Sales | 24.4 | 158.9 | 66.9 | 2.0 | 3.2 |
Price To Book Price To Book | 11.4 | 95.3 | -22.2 | 2.8 | 4.3 |
EV To EBITDA EV To EBITDA | -26.8 | -29.6 | -15.7 | 2.7 | 3.1 |
GPM GPM% | 84.1 | 36.7 | 40.2 | 97.8 | 97.8 |
OPM OPM% | -89.7 | -532.3 | -450.3 | 85.1 | 84.7 |
NPM NPM% | -93.2 | -512.6 | -477.3 | 82.7 | 84.7 |
ROCE ROCE% | -40.7 | -206.1 | -642.0 | 83.6 | 115.4 |
ROE ROE% | -43.4 | -307.9 | 157.9 | 116.0 | 113.4 |
ROA ROA% | -26.8 | -75.2 | -102.1 | 71.5 | 97.7 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 5,824 | 12,006 | 4,803 | 3,719 | 6,171 |
Price To Earnings Price To Earnings | 2.4 | 3.8 | |||
Price To Sales Price To Sales | 24.4 | 158.9 | 66.9 | 2.0 | 3.2 |
Price To Book Price To Book | 11.4 | 95.3 | -22.2 | 2.8 | 4.3 |
EV To EBITDA EV To EBITDA | -26.8 | -29.6 | -15.7 | 2.7 | 3.1 |
GPM GPM% | 84.1 | 36.7 | 40.2 | 97.8 | 97.8 |
OPM OPM% | -89.7 | -532.3 | -450.3 | 85.1 | 84.7 |
NPM NPM% | -93.2 | -512.6 | -477.3 | 82.7 | 84.7 |
ROCE ROCE% | -40.7 | -206.1 | -642.0 | 83.6 | 115.4 |
ROE ROE% | -43.4 | -307.9 | 157.9 | 116.0 | 113.4 |
ROA ROA% | -26.8 | -75.2 | -102.1 | 71.5 | 97.7 |
| Market CapitalizationMkt CapCr | 6,171 | 3,724 | 3,302 | 2,059 | 2,058 | 1,569 | 963 |
| Close PriceClose₹ | 190.16 | 84.16 | 468.95 | 21.90 | 335.95 | 1,110.15 | 817.60 |
| IndustryIndustry | Pharma Others | Pharma Others | Pharma Others | Pharma Others | Pharma Others | Pharma Others | Pharma Others |
| Price To EarningsPE | 3.77 | 82.51 | 9.74 | 21.68 | 111.61 | 5.67 | 19.57 |
| Price To SalesPS | 3.19 | 32.91 | 1.39 | 3.97 | 2.85 | 1.71 | 0.90 |
| RevenueRevenueCr | 1,932 | 113 | 2,369 | 518 | 721 | 918 | 1,068 |
| Revenue Growth TTMRev Gr TTM% | 3,141.0% | 222.2% | 6.4% | 0.6% | 19.4% | 11.3% | 42.7% |
| PAT Growth TTMPAT Gr TTM% | 712.6% | 270.5% | 283.1% | 51.6% | 323.7% | 317.3% | 16.8% |
| Market CapitalizationMkt CapCr | 6,171 | 3,724 | 3,302 | 2,059 | 2,058 | 1,569 | 963 |
| Close PriceClose₹ | 190.16 | 84.16 | 468.95 | 21.90 | 335.95 | 1,110.15 | 817.60 |
| IndustryIndustry | Pharma Others | Pharma Others | Pharma Others | Pharma Others | Pharma Others | Pharma Others | Pharma Others |
| Price To EarningsPE | 3.77 | 82.51 | 9.74 | 21.68 | 111.61 | 5.67 | 19.57 |
| Price To SalesPS | 3.19 | 32.91 | 1.39 | 3.97 | 2.85 | 1.71 | 0.90 |
| RevenueRevenueCr | 1,932 | 113 | 2,369 | 518 | 721 | 918 | 1,068 |
| Revenue Growth TTMRev Gr TTM% | 3,141.0% | 222.2% | 6.4% | 0.6% | 19.4% | 11.3% | 42.7% |
| PAT Growth TTMPAT Gr TTM% | 712.6% | 270.5% | 283.1% | 51.6% | 323.7% | 317.3% | 16.8% |